Caricamento...
Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib
BACKGROUND AND AIMS: Sorafenib is the standard of care for patients with advanced hepatocellular carcinoma (HCC), yet treatment safety may be challenged by portal hypertension. We therefore assessed the prevalence, risk factors and clinical consequences of esophageal varices (EVs) in sorafenib-treat...
Salvato in:
| Pubblicato in: | United European Gastroenterol J |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4924436/ https://ncbi.nlm.nih.gov/pubmed/27403302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640615615041 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|